Active Ingredient: DROXIDOPA
Proprietary Name: DROXIDOPA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A212835
Product Number: 001
Approval Date: Feb 18, 2021
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information